Research advancements require advanced technology. PETQuant is a research-specific component of NeuroQuant® that provides researchers and physicians with a cutting-edge tool in the study of frontotemporal dementia and Alzheimer’s disease. PETQuant automatically quantifies PET tracer bindings localized to brain structures identified by NeuroQuant 3D T1 MRI segmentation. Users can select between two tracers for metabolic (FDG) and amyloid-based (Florbetapir) analysis. Visual and statistical (Z-score) comparisons of each normalized regional PET tracer value are then compared to normative population data. Compatible with GE, Philips, and Siemens PET and PET/CT scanners, PETQuant enables better insight that leads to breakthrough discoveries.
Benefits and Features
How Will PETQuant Improve Your PET Analysis?
Amyloid Deposition and Metabolism Analysis
Option available to license two separate reports that correspond to the PET tracer used.
Easy-to-Read Reports
Color-coded graphical presentation simplifies quantitative reads.
24/7 Access
Cortechs.ai’s secure, cloud-based system provides access anytime, from virtually anywhere.
Export Raw Rata
Data is easily exported to a CSV file for your research needs.
Powered by NeuroQuant
Provides brain segmentation that allows subregional tracer quantification in native patient brain space.
Obtain a Detailed Look
A color-blended brain segmentation overlay of the 3D MR series enables closer inspection on a PACS or other DICOM.
Discover the Clinical Benefits of PETQuant
See how quantitative imaging fits easily into your workflow
Start a conversation